Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.430
-0.080 (-2.28%)
At close: Apr 10, 2026, 4:00 PM EDT
3.513
+0.083 (2.43%)
After-hours: Apr 10, 2026, 7:36 PM EDT
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $607.38 million as of April 10, 2026. Its market cap has increased by 143.98% in one year.
Market Cap
607.38M
Enterprise Value
546.13M
1-Year Change
143.98%
Ranking
Category
Stock Price
$3.43
Market Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $607.38M, a decrease of -62.68%. That is a compound annual growth rate of -24.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 607.38M | -1.13% |
| Dec 31, 2025 | 614.32M | 64.88% |
| Dec 31, 2024 | 372.58M | -54.41% |
| Dec 29, 2023 | 817.15M | -49.22% |
| Dec 30, 2022 | 1.61B | -1.12% |
| Oct 20, 2022 | 1.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LB Pharmaceuticals | 665.11M |
| Gyre Therapeutics | 661.11M |
| Alpha Tau Medical | 646.87M |
| Forte Biosciences | 636.24M |
| Crescent Biopharma | 634.39M |
| Ocugen | 631.87M |
| MiMedx Group | 598.72M |
| Tectonic Therapeutic | 583.77M |